ODX Share Price: Live Stock Chart, History & 2026 Prediction

Welcome to our comprehensive guide to the historical and current performance of the odx share price. Now trading as Cambridge Nutritional Sciences (CNSL), this diagnostics company has undergone significant restructuring. This article explores CNSL’s current valuation, historical market movements, and what smart investors can expect from the stock as we move deeper into 2026.

What Is CNSL Trading at Right Now?

Currently, shares in Cambridge Nutritional Sciences are trading at approximately 2.05p on the London Stock Exchange (LSE). Following its strategic pivot away from global health toward personalized nutrition, the stock has stabilized at a micro-cap valuation of roughly £5 million.

Where Does CNSL Currently Stand Against Its 52-Week Range?

The stock is currently languishing near the lower end of its recent trading channel. Over the past year, CNSL has traded within a 52-week range of 1.80p to 4.25p. At 2.05p, the shares are trading at a substantial discount to their 52-week highs, reflecting ongoing market skepticism regarding the company's turnaround timeline.

How Has CNSL Moved in the Past 30 Days?

In recent weeks, CNSL has experienced modest fluctuations. The stock opened 2026 around 1.94p, briefly touching 2.20p in the first quarter, before settling back down to the 2.05p mark by May 2026. Trading volumes remain relatively thin, which means minor buying or selling pressure can lead to outsized percentage movements.

What Drove CNSL to Its Current Price Level?

CNSL’s current price reflects a challenging transitional phase for the business. The market is waiting for concrete financial results that prove the company's strategic pivot has been fully executed and is generating sustainable free cash flow.

What Business or Financial Developments Have Shaped CNSL's Price?

The most defining shift was the September 2023 name change from Omega Diagnostics to Cambridge Nutritional Sciences, coupled with the disposal of its loss-making CD4 business. The company relocated its headquarters to Ely, Cambridgeshire, and refocused exclusively on food sensitivity testing, particularly its FoodPrint® brand. Initial production yield issues and high raw material costs previously suppressed margins, keeping the share price depressed despite ongoing revenue generation.

How Did Broader Market Conditions Affect CNSL Stock?

High interest rates and risk-off sentiment in the UK small-cap market have severely impacted AIM-listed healthcare stocks. While traditional investors might prefer the stability of a barclays share price dividend or rely on a blue-chip barclays share price forecast, micro-cap investors demand aggressive growth to justify the risk. Furthermore, speculative capital has often rotated into other volatile sectors, leaving stocks like CNSL overlooked in favor of sudden movers, akin to a volatile mode stock or the rapid shifts seen in a boil share price or arb share price.

What Does CNSL's Price History Show Over the Long Term?

The long-term chart for the former Omega Diagnostics is a story of extreme volatility. It has been heavily influenced by the COVID-19 pandemic and the company's subsequent corporate restructuring.

How Has CNSL Performed Year by Year?

Prior to 2020, the stock traded quietly as a niche diagnostics business. During the pandemic, the stock surged dramatically on the promise of COVID-19 testing contracts. However, when these government contracts failed to materialize into long-term profits, the stock suffered a multi-year decline. By 2023, the share price had collapsed back to penny-stock levels, leading to a complete corporate overhaul.

What Were the Biggest Peaks and Drops in CNSL's History?

The historical peak occurred during the 2020 and 2021 pandemic frenzy, when shares skyrocketed on speculative Covid testing hype. The biggest drop followed shortly after, as operational failures and the withdrawal from the global health diagnostics market wiped out those temporary gains. Over the last 365 days leading up to May 2026, the stock has further declined by roughly 24%, heavily underperforming the broader FTSE All-Share Index.

Where Is CNSL Share Price Headed in 2026?

Looking forward, 2026 is a critical "show me" year for Cambridge Nutritional Sciences. The company must prove that its streamlined focus on personalized nutrition is profitable and scalable.

What Do Analyst Targets and Forecasts Say About CNSL in 2026?

According to recent broker notes reported by Stockopedia and Investing.com, the consensus 12-month analyst target price for CNSL stands at an optimistic 6.00p. If achieved, this would represent a nearly 192% upside from the current 2.05p level. However, this "Strong Buy" consensus hinges entirely on the company successfully scaling its North American market expansion and improving manufacturing yields.

What Key Risks Could Push CNSL Lower This Year?

The primary risk remains operational execution. Key threats to the share price include:

• Supply Chain Costs: If raw material costs spike, the company could face further EBITDA losses.
• Manufacturing Yields: The company has previously struggled with FoodPrint® production yields, and any regression here will directly harm gross margins.
• Liquidity Concerns: AIM-listed micro-caps constantly face funding pressures; if cash reserves dwindle, the company might be forced into a highly dilutive equity raise.

What Catalysts Could Drive CNSL Higher in 2026?

Stronger-than-expected sales in the North American market represent the most significant potential catalyst. The company recently entered agreements with US testing laboratories to install and validate its core FoodPrint® product. Positive earnings reports confirming improved gross margins and a return to profitability could easily spark a retail-driven rally, much like the sudden spikes occasionally seen in a genedrive share price.

Is CNSL Worth Buying at Its Current Price?

For risk-tolerant investors, CNSL presents an interesting speculative opportunity. The core FoodPrint® product serves a growing market in personalized nutrition, and the £5 million market capitalization arguably undervalues the operational side of the business if management can achieve reliable profitability.

Below is a brief summary of the stock's current investment profile:

However, cautious investors must remember that this is a turnaround play. It requires patience, a high tolerance for volatility, and close monitoring of upcoming earnings reports.

FAQs about odx share price

Is Omega Diagnostics still trading under the ticker ODX?

No, Omega Diagnostics no longer trades under the ODX ticker. The company changed its ticker symbol to CNSL following a corporate rebranding in September 2023.

Did Omega Diagnostics change its name and ticker symbol?

Yes, the company officially changed its name to Cambridge Nutritional Sciences plc. Alongside this name change, the London Stock Exchange ticker was successfully updated from ODX to CNSL.

What is the current share price of Cambridge Nutritional Sciences (formerly ODX)?

As of May 2026, shares in Cambridge Nutritional Sciences are trading at approximately 2.05p. The stock has experienced a recent 52-week trading range between 1.80p and 4.25p.

How has the ODX share price performed historically?

The historical share price experienced a massive, short-lived surge during the 2020 pandemic before crashing due to operational setbacks. Today, the restructured company trades at a fraction of its former pandemic-era highs.

Conclusion

Tracking the odx share price evolution into CNSL offers a textbook lesson in small-cap volatility and corporate restructuring. While the current 2.05p valuation reflects past missteps, the focused nutrition strategy and 6.00p analyst target present a speculative upside. Investors should weigh the significant execution risks against the potential for a long-term turnaround.